The mission of our Perimenopause in Brain Aging and Alzheimer's Disease Program Project is to discover the transformations that occur in the brain during the perimenopausal transition that can result in phenotypes predictive of risk for development of AD pathology. The Mission of Project 5 is to determine the mechanism the perimenopausal hot flash which is the most common symptom of menopause. The hot flash occurs in 60-85% of Western women during the perimenopausal transition. To date, the mechanism of the menopausal hot flash remains undetermined. We propose that the temperature dysregulatlon of the perimenopause is the result of a bioenergetic shift in the brain. Utilizing rodent models of human perimenopause, Project 5 will achieve its mission by determining: (1) in Aim 1 the physiological and bioenergetic phenotype of a preclinical model of the hot flash;(2) in Aim 2 the underlying neural mechanisms of the perimenopausal hot flash and (3) in Aim 3 the translational validity and potential of the proposed hot flash mechanism. To address our hypotheses, we will experimentally determine brain metabolism, lipidomic profile, mitochondrial function and bioenergetic gene expression during the period of perimenopausal temperature dysregulatlon. Network and pathway bioinformatic analyses will be conducted to generate an integrative systems level interpretation across experimental outcomes. Discovery of the mechanisms of action that underlie the perimenopausal hot flash will inform understanding of the neurobiological transformations that occur during this aging transition. Further, these mechanisms of action may inform understanding of potential risks for developing hypometabolism in brain and ultimately an at-risk-for Alzheimer's disease phenotype. From a translational perspective, determining the mechanism of the hot flash could generate multiple targets for rationally designed therapeutic interventions. Clinically, the hot flash remains an unresolved issue in women's health and affects women transitioning through natural or induced menopause, those undergoing treatment for uterine fibroids or therapy for breast cancer. Moreover, the hot flash is a common consequence of therapy for prostate cancer in men and of type 2 diabetes in both sexes.

Public Health Relevance

Why women experience the hot flash during menopause remains unknown. Project 5 of our Perimenopause Program Project will determine the mechanism of the menopausal hot flash to better understand this aging transition in women. Understanding why the menopausal hot flash occurs could also provide insights into why breast cancer and prostate cancer survivors and persons with type 2 diabetes also experience hot flashes and strategies to prevent and treat the hot flash developed.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
3P01AG026572-09S1
Application #
8667894
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Wise, Bradley C
Project Start
2005-07-01
Project End
2016-05-31
Budget Start
2014-08-15
Budget End
2015-05-31
Support Year
9
Fiscal Year
2014
Total Cost
$258,624
Indirect Cost
$101,446
Name
University of Southern California
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Uchoa, Mariana F; Moser, V Alexandra; Pike, Christian J (2016) Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors. Front Neuroendocrinol 43:60-82
Yin, Fei; Sancheti, Harsh; Patil, Ishan et al. (2016) Energy metabolism and inflammation in brain aging and Alzheimer's disease. Free Radic Biol Med 100:108-122
Finch, Caleb E; Shams, Sara (2016) Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci 39:625-37
Cacciottolo, Mafalda; Christensen, Amy; Moser, Alexandra et al. (2016) The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol Aging 37:47-57
Rettberg, Jamaica R; Dang, Ha; Hodis, Howard N et al. (2016) Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. Neurobiol Aging 40:155-63
Finch, Caleb E; Crimmins, Eileen M (2016) Constant molecular aging rates vs. the exponential acceleration of mortality. Proc Natl Acad Sci U S A 113:1121-3
Finch, Caleb E; McMahon, Andrew P (2016) Stem cells for all ages, yet hostage to aging. Stem Cell Investig 3:11
Karim, Roksana; Dang, Ha; Henderson, Victor W et al. (2016) Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life. J Am Geriatr Soc 64:2448-2456
Wang, Yiwei; Brinton, Roberta D (2016) Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex. Front Aging Neurosci 8:232
Moser, V Alexandra; Pike, Christian J (2016) Obesity and sex interact in the regulation of Alzheimer's disease. Neurosci Biobehav Rev 67:102-18

Showing the most recent 10 out of 87 publications